Cholinesterase inhibitors and memantine are currently the only symptomatic medications for AD patients, but although these medications can help with cognition and global functioning, there is little evidence that these pharmacotherapies are neuroprotective or prevent disease progression [179,180]. Here, BCHE is linked to Alzheimer disease.